PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue

Background. In the last few decades, a better knowledge of the inflammatory pathways involved in the pathogenesis of Inflammatory Bowel Disease (IBD) has promoted biological therapy as an important tool to treat IBD patients. However, in spite of a wider spectrum of biological drugs, a significant p...

Descripción completa

Detalles Bibliográficos
Autores principales: Spadaccini, Marco, D’Alessio, Silvia, Peyrin-Biroulet, Laurent, Danese, Silvio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486098/
https://www.ncbi.nlm.nih.gov/pubmed/28617319
http://dx.doi.org/10.3390/ijms18061276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486098/
https://www.ncbi.nlm.nih.gov/pubmed/28617319
http://dx.doi.org/10.3390/ijms18061276

Ejemplares similares